DouglasEFeltnerMD

PubMed

• 105 citations
  AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort.
  Samiah Al-Zaidy, Stephen J. Kolb, Linda Lowes, Lindsay N. Alfano, Richard Shell, Kathleen Church, Sukumar Nagendran, Douglas M. Sproule, Douglas E. Feltner, Courtney W...> ;Journal of Neuromuscular Diseases. 2019 Jan 1
• 117 citations
  Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy
  Linda Lowes, Lindsay N. Alfano, W. David Arnold, Richard Shell, Thomas W. Prior, Markus McColly, Kelly J. Lehman, Kathleen Church, Douglas M. Sproule, Sukumar Nagendra...> ;Pediatric Neurology. 2019 Sep 1
• 61 citations
  Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients.
  Daniel C. Malone, Rebecca Dean, Ramesh Arjunji, Ivar Jensen, Phil Cyr, Beckley Miller, Benit Maru, Douglas M. Sproule, Douglas E. Feltner, Omar H. Dabbous> ;Journal of Market Access & Health Policy. 2019 May 8
• 2 citations
  Translational and Early Phase Strategies for Treatment Development: Report of ISCTM Autumn 2013 Symposium.
  Jared W. Young, William Z. Potter, Steve Riley, Geert J. Groeneveld, Bruce J. Kinon, Mike F. Egan, Douglas E. Feltner> ;Innovations in Clinical Neuroscience. 2015 Mar 1
• 4 citations
  Study Site Experiences and Attitudes Toward Prospective Assessments of Suicidal Ideation and Behavior in Clinical Trials: Results of an Internet-based Survey.
  Michelle Stewart, Adam Butler, Larry Alphs, Phillip B. Chappell, Douglas Feltner, William R. Lenderking, Atul R. Mahableshwarkar, Clare Makumi, Sarah Dubrava> ;Innovations in Clinical Neuroscience. 2013 May 1
• 94 citations
  Vocal acoustic biomarkers of depression severity and treatment response.
  James C. Mundt, Adam P. Vogel, Douglas Feltner, William R. Lenderking> ;Biological Psychiatry. 2012 Oct 1
• 25 citations
  Initial Validity and Reliability Data on the Columbia–Suicide Severity Rating Scale
  Phillip B. Chappell, Douglas Feltner, Clare Makumi, Michelle Stewart> ;The American Journal of Psychiatry. 2012 Jun 1
• 20 citations
  An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD.
  Suzanne M. Sutherland, Lenard A. Adler, Crystal Chen, Michael D. Smith, Douglas E. Feltner> ;The Journal of Clinical Psychiatry. 2012 Jan 10
• 16 citations
  Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study.
  John H. Greist, Maria Liu-Dumaw, Edward Schweizer, Douglas Feltner> ;International Clinical Psychopharmacology. 2011 Sep 1
• 36 citations
  Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
  Douglas Feltner, Maria Liu-Dumaw, Edward Schweizer, Robert J. Bielski> ;International Clinical Psychopharmacology. 2011 Jul 1
• 7 citations
  Evaluation of the subjective and reinforcing effects of diphenhydramine, levetiracetam, and valproic acid.
  Douglas Feltner, George M. Haig> ;Journal of Psychopharmacology. 2011 Jun 1
• 112 citations
  Identifying HAM‐A cutoffs for mild, moderate, and severe generalized anxiety disorder
  Louis S. Matza, Robert Morlock, Chris Sexton, Karen G. Malley, Douglas Feltner> ;International Journal of Methods in Psychiatric Research. 2010 Dec 1
• 3 citations
  Pharmacodynamic differentiation of lorazepam sleepiness and dizziness using an ordered categorical measure
  Mohamed A. Kamal, David Smith, Jack Cook, Douglas Feltner, Allen Moton, Daniele Ouellet> ;Journal of Pharmaceutical Sciences. 2010 Aug 1
• 143 citations
  Psychometric evaluation of a visual analog scale for the assessment of anxiety.
  Valerie Williams, Robert Morlock, Douglas Feltner> ;Health and Quality of Life Outcomes. 2010 Jun 8
• 36 citations
  Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.
  Jonathan R. T. Davidson, Douglas Feltner, Ashish Dugar> ;Primary Care Companion to the Journal of Clinical Psychiatry. 2010 Mar 4
• 45 citations
  Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder
  R. Bruce Lydiard, Karl Rickels, Barry K Herman, Douglas Feltner> ;The International Journal of Neuropsychopharmacology. 2010 Mar 1
• 13 citations
  Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial
  Douglas Feltner, Cheryl D. Hill, William R. Lenderking, Valerie Williams, Robert Morlock> ;Journal of Psychiatric Research. 2009 Oct 1
• 4 citations
  Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage-gated calcium channel alpha-2-delta subunit
  Brian Corrigan, Douglas Feltner, Daniele Ouellet, John L. Werth, Allen Moton, Gordon D. Gibson> ;British Journal of Clinical Pharmacology. 2009 Aug 1
• 6 citations
  Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder.
  Douglas Feltner, J. Harness, Jerri Brock, Angelo Sambunaris, Joseph C. Cappelleri, Robert Morlock> ;CNS Neuroscience & Therapeutics. 2009 Mar 1
• 20 citations
  The use of a clinical utility index to compare insomnia compounds: a quantitative basis for benefit-risk assessment.
  Daniele Ouellet, John L. Werth, N Parekh, Douglas Feltner, Bruce Gerald Mccarthy, Richard L. Lalonde> ;Clinical Pharmacology and Therapeutics. 2009 Mar 1
• 3 citations
  Development and evaluation of the Daily Assessment of Symptoms - Anxiety (DAS-A) scale to evaluate onset of symptom relief in patients with generalized anxiety disorder.
  Robert Morlock, Valerie Williams, Joseph C. Cappelleri, J. Harness, Sheri Fehnel, Jean Endicott, Douglas Feltner> ;Journal of Psychiatric Research. 2008 Oct 1
• 172 citations
  A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.
  Brendon Binneman, Douglas Feltner, Sheela Kolluri, Yuanjun Shi, Ruolun Qiu, Thomas Stiger> ;The American Journal of Psychiatry. 2008 May 1
• 79 citations
  Long-term efficacy of pregabalin in generalized anxiety disorder
  Douglas Feltner, Hans-Ulrich Wittchen, Richard J. Kavoussi, Jerri Brock, Francesca Baldinetti, Atul C. Pande> ;International Clinical Psychopharmacology. 2008 Jan 1
• 2 citations
  The patient experience of depression and remission: focus group results.
  Lori Frank, Louis S. Matza, Jennifer Hanlon, Sally Mannix, Dennis A. Revicki, Douglas Feltner, Robert Morlock> ;The Journal of Nervous and Mental Disease. 2007 Aug 1
• 258 citations
  Ca2+ channel α2δ ligands: novel modulators of neurotransmission
  David J. Dooley, Charles Taylor, Sean D. Donevan, Douglas Feltner> ;Trends in Pharmacological Sciences. 2007 Feb 1
• Join now to see all